Patents by Inventor Choung Kim

Choung Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8099732
    Abstract: Techniques are presented for skew exception detection within a parallel processing environment. A potential exception is detected when a highest load of a processor within the parallel processing environment exceeds an average load within the parallel processing environment by a given threshold. The potential exception can become a legitimate exception when it exists for a qualified period or time or when it exists and no qualified period of time is noted. In an embodiment, checks for the potential exception occur and are wholly contained within a given configurable interval.
    Type: Grant
    Filed: October 17, 2006
    Date of Patent: January 17, 2012
    Assignee: Teradata US, Inc.
    Inventors: Hoa Tran, Anita Richards, Douglas Brown, Choung Kim
  • Publication number: 20080133608
    Abstract: A system for and method of managing database workloads. The workload managing system comprises a historical data collector arranged to collect historical data indicative of historical database performance trends, and a current data collector arranged to collect substantially current data indicative of substantially current database performance. The system is arranged to compare the collected historical data with the collected substantially current data and to modify operation of the database based on the comparison.
    Type: Application
    Filed: December 5, 2006
    Publication date: June 5, 2008
    Inventors: Douglas Brown, Choung Kim, Anita Richards
  • Publication number: 20080107628
    Abstract: A compound of Formula I, Formula II, Formula III, or Formula IV: or a pharmaceutically acceptable salt, solvate, and/or ester thereof, therapeutic compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
    Type: Application
    Filed: July 6, 2007
    Publication date: May 8, 2008
    Inventors: Constantine Boojamra, James Chen, Alan Huang, Choung Kim, Kuei-Ying Lin, Richard Mackman, David Oare, Jason Perry, Oliver Saunders, Sundaramoorthi Swaminathan, Lijun Zhang
  • Publication number: 20080092142
    Abstract: Techniques are presented for skew exception detection within a parallel processing environment. A potential exception is detected when a highest load of a processor within the parallel processing environment exceeds an average load within the parallel processing environment by a given threshold. The potential exception can become a legitimate exception when it exists for a qualified period or time or when it exists and no qualified period of time is noted. In an embodiment, checks for the potential exception occur and are wholly contained within a given configurable interval.
    Type: Application
    Filed: October 17, 2006
    Publication date: April 17, 2008
    Inventors: Hoa Tran, Anita Richards, Douglas Brown, Choung Kim
  • Publication number: 20080076738
    Abstract: Novel HIV integrase inhibitor compounds having at least one phosphonate group, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
    Type: Application
    Filed: April 11, 2005
    Publication date: March 27, 2008
    Inventors: Zhenhong Cai, Xiaowu Chen, Maria Fardis, Salman Jabri, Haolun Jin, Choung Kim, Samuel Metobo, Michael Mish, Richard Pastor
  • Publication number: 20080070920
    Abstract: The invention is related to compounds of Formula (I), (II), or (III): or a pharmaceutically acceptable salt, solvate, ester, and/or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
    Type: Application
    Filed: July 24, 2007
    Publication date: March 20, 2008
    Inventors: Hongyan Guo, Choung Kim, Hae Kim, Chong-Kyo Lee, Ill Lee, Michael Mitchell, Jong Son, Lianhong Xu
  • Publication number: 20080057031
    Abstract: The invention is related to anti-viral phosphinate compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: July 6, 2007
    Publication date: March 6, 2008
    Applicant: Gilead Sciences, Inc.
    Inventors: Anthony Casarez, Kleem Chaudhary, Aesop Cho, Michael Clarke, Edward Doerffler, Maria Fardis, Choung Kim, Hyungjung Pyun, Xiaoning Sheng, Jianying Wang
  • Publication number: 20070244148
    Abstract: The present invention relates to a pharmaceutical composition for the treatment or prevention of viral infections comprising as an active principle at least one imidazo[4,5-c]pyridine prodrug having the general formula (Z): The invention also relates to processes for the preparation of compounds according to the invention having above mentioned general formula and their use as a medicine or to treat or prevent viral infections.
    Type: Application
    Filed: December 21, 2004
    Publication date: October 18, 2007
    Inventors: Steven Bondy, Eric Dowdy, Choung Kim, David Oare, Johan Neyts, Vahid Zia, Gerhard Purstinger
  • Publication number: 20070190523
    Abstract: The invention relates to methods and compositions for identifying compounds having therapeutic activity against human immunodeficiency virus (HIV).
    Type: Application
    Filed: November 6, 2003
    Publication date: August 16, 2007
    Inventors: Gabriel Birkus, James Chen, Xiaowu Chen, Tomas Cihlar, Eugene Eisenberg, Marcos Hatada, Gong-Xin He, Choung Kim, William Lee, Martin McDermott, Sundaramoorthi Swaminathan
  • Publication number: 20070185007
    Abstract: Aza-quinolinol phosphonate compounds and methods for inhibition of HIV-integrase are disclosed. Formula (I). Ar is aryl or heteroaryl connecting R6 to L. L is a bond or a linker connecting a ring atom of Ar to N. The ring atoms, X1-X5 may be N, substituted nitrogen, or substituted carbon, and form rings. The compounds include at least one phosphonate group covalently attached at any site.
    Type: Application
    Filed: September 17, 2004
    Publication date: August 9, 2007
    Inventors: Haolun Jin, Choung Kim, Peter Nelson
  • Publication number: 20070078081
    Abstract: The invention is related to HCV inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compound.
    Type: Application
    Filed: July 14, 2006
    Publication date: April 5, 2007
    Inventors: Anthony Casarez, Kleem Chaudhary, Choung Kim, Darren McMurtrie, Xiaoning Sheng
  • Publication number: 20070072809
    Abstract: The invention is related to HCV inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: July 14, 2006
    Publication date: March 29, 2007
    Inventors: Aesop Cho, Choung Kim, Xiaoning Sheng
  • Publication number: 20070072831
    Abstract: Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
    Type: Application
    Filed: May 16, 2006
    Publication date: March 29, 2007
    Inventors: Zhenhong Cai, Salman Jabri, Haolun Jin, Choung Kim, Rachael Lansdown, Samuel Metobo, Michael Mish, Richard Pastor
  • Publication number: 20070010489
    Abstract: Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit 5 HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as in assays for the detection of HIV protease.
    Type: Application
    Filed: April 25, 2003
    Publication date: January 11, 2007
    Inventors: Murty Arimilli, Mark Becker, Clifford Bryant, James Chen, Xiaowu Chen, Azar Dastgah, Maria Fardis, Gong-Xin He, Haolun Jin, Choung Kim, William Lee, Christopher Lee, Kuei-Ying Lin, Hongtao Liu, Richard Mackman, Michael Mitchell, Peter Nelson, Hyung-Jung Pyun, Tanisha Rowe, Mark Sparacino, Sundaramoorthi Swaminathan, James Tario, Jianying Wang, Matthew Wiliams, Lianhong Xu, Zheng-Yu Yang, Richard Yu, Jiancun Zhang, Lijun Zhang
  • Publication number: 20060264404
    Abstract: The invention is related to phosphorus substituted therapeutic agents, compositions containing such phosphorus substituted agents, and therapeutic methods that include the administration of such phosphorus substituted agents, as well as to processes and intermediates useful for preparing such agents.
    Type: Application
    Filed: October 25, 2005
    Publication date: November 23, 2006
    Inventors: Constantine Boojamra, Carina Cannizzaro, James Chen, Xiaowu Chen, Aesop Cho, Lee Chong, Manoj Desai, Maria Fardis, Craig Gibbs, Ralph Hirschmann, Alan Huang, Haolun Jin, Choung Kim, Thorsten Kirschberg, Steven Krawczyk, Christopher Lee, William Lee, Kuei-Ying Lin, Richard Mackman, David Markevitch, Peter Nelson, David Oare, Vidya Prasad, Hyung-Jung Pyun, Adrian Ray, Rosemarie Sherlock, Sundaramoorthi Swaminathan, William Watkins, Jennifer Zhang, Lijun Zhang
  • Publication number: 20060252715
    Abstract: Disclosed are compounds represented by formulae I, II, and III, and the compositions and methods thereof for treating viral infections caused by a Flaviviridae family virus.
    Type: Application
    Filed: February 28, 2006
    Publication date: November 9, 2006
    Inventors: Jesse Keicher, Christopher Roberts, Sebastian Johannes Liehr, Xiaoling Zheng, Marija Prhavc, Vivek Rajwanshi, Ronald Griffith, Choung Kim
  • Publication number: 20060217410
    Abstract: Tricyclic compounds according to the structure below, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed. Formula (I). A1 and A2 are moieties forming a five, six, or seven membered ring. L is a bond or a linker connecting a ring atom of Ar to N. X is O, S, or substituted nitrogen. Ar is aryl or heteroaryl. Q is N, +NR, or CR4. The aryl carbons may be independently substituted with substituents other than hydrogen. The compounds may include prodrug moieties covalently attached at any site.
    Type: Application
    Filed: October 16, 2003
    Publication date: September 28, 2006
    Inventors: James Chen, Xiaowu Chen, Maria Fardis, Haolun Jin, Choung Kim, Laura Schacherer
  • Publication number: 20060128692
    Abstract: Phosphorus-substituted imidazole compounds with anti-HIV properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit reverse transcriptase activity and are useful therapeutically for the inhibition of such enzymes, as well as in assays for the detection of such enzymes.
    Type: Application
    Filed: April 25, 2003
    Publication date: June 15, 2006
    Applicant: Gilead Sciences, INC
    Inventors: James Chen, Xiaowu Chen, Choung Kim, William Lee, Christopher Lee, Peter Nelson, James Tario, Lianhong Xu
  • Publication number: 20060122123
    Abstract: The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: July 18, 2005
    Publication date: June 8, 2006
    Inventors: Kleem Chaudhary, Melissa Fleury, Choung Kim, Darren McMurtrie, Xiaoning Sheng
  • Publication number: 20060116356
    Abstract: Novel HIV integrase inhibitor compounds having at least one phosphonate group, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
    Type: Application
    Filed: April 14, 2005
    Publication date: June 1, 2006
    Inventors: Zhenhong Cai, Xiaowu Chen, Maria Fardis, Salman Jabri, Haolun Jin, Choung Kim, Samuel Metobo, Michael Mish, Richard Pastor